Targeting Histone Lactylation With RNA Offers New Strategy Against Pancreatic Cancer
A comprehensive review outlines how histone lactylation drives pancreatic cancer resistance and evaluates RNA therapies targeting this metabolic-epigenetic axis.
A comprehensive review outlines how histone lactylation drives pancreatic cancer resistance and evaluates RNA therapies targeting this metabolic-epigenetic axis.
A single-cell RNA sequencing study reveals that an ETS2-expressing epithelial cell subpopulation promotes neoadjuvant chemoimmunotherapy resistance in esophageal squamous cell ...
A review in Discover Oncology details how Notch signaling pathways drive cancer drug resistance through mechanisms involving apoptosis, DNA repair, ...
A 2026 review in Clinical Epigenetics examines how ubiquitination and acylation modifications interact to drive cancer drug resistance and identifies ...
An editorial summarizing eight contributions describes cancer drug resistance as an adaptive process involving genetic, epigenetic, metabolic, signalling and microenvironmental ...
A new review in Molecular Cancer maps how approved drugs from outside oncology could be repurposed, under a strict mechanism-first ...
In the realm of cancer therapy, particularly in the treatment of multiple myeloma, researchers have recently focused their efforts on ...
In the relentless battle against cancer, understanding how tumors evolve to resist treatment remains one of the most formidable challenges ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.